{
  "symbol": "MDXG",
  "company_name": "Mimedx Group Inc",
  "ir_website": "https://investors.mimedx.com/ir-contacts",
  "structured_data": [
    {
      "section_name": "News Releases",
      "links": [
        {
          "title": "News Releases",
          "url": "https://investors.mimedx.com/news-releases",
          "content": "[Skip to content](#lfg-main-content)\n\n[ ![MIMEDX Group, Inc.](/sites/g/files/knoqqb79066/themes/site/nir_pid904/dist/images/MIMEDX.png) ](https://www.mimedx.com/)\n\n  * [Overview](/investor-overview)\n  * [News Releases](/news-releases)\n  * [Events & Presentations](/events-and-presentations)\n  * [Corporate Governance]()\n    * [Management](https://www.mimedx.com/company/management-team/)\n    * [Board of Directors](https://www.mimedx.com/management-team-board-of-directors/)\n    * [Committee Composition](/corporate-governance/committee-composition)\n    * [Documents and Charters](/corporate-governance/highlights)\n    * [ESG](https://www.mimedx.com/sustainability)\n  * [SEC Filings](/financial-information/sec-filings)\n  * [Stock Information]()\n    * [Stock Quote & Chart](/stock-information/stock-quote-and-chart)\n    * [Historical Price Lookup](/stock-information/historical-price-lookup)\n    * [Investment Calculator](/stock-information/investment-calculator)\n    * [Analyst Coverage](/stock-information/analyst-coverage)\n  * [Information Request]()\n    * [Request Form](/information-request)\n    * [Investor FAQs](/investor-faqs)\n\n\n\n#  News Releases \n\n## Keyword Search\n\nYear All Years202420232022\n\n2024\n\nNovember 14, 2024 \n\n[MIMEDX’s Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs](/news-releases/news-release-details/mimedxs-advocacy-rein-runaway-medicare-spend-skin-substitutes)\n\n[](/node/18146/pdf)\n\nNovember 4, 2024 \n\n[MIMEDX to Participate in Upcoming Investor Conferences](/news-releases/news-release-details/mimedx-participate-upcoming-investor-conferences-6)\n\n[](/node/18106/pdf)\n\nOctober 30, 2024 \n\n[MIMEDX Announces Third Quarter 2024 Operating and Financial Results](/news-releases/news-release-details/mimedx-announces-third-quarter-2024-operating-and-financial)\n\n[](/node/18091/pdf)\n\nOctober 14, 2024 \n\n[MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30](/news-releases/news-release-details/mimedx-host-third-quarter-2024-operating-and-financial-results)\n\n[](/node/18066/pdf)\n\nOctober 8, 2024 \n\n[MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue](/news-releases/news-release-details/mimedx-points-new-york-times-article-vast-benefits-placental)\n\n[](/node/18051/pdf)\n\nOctober 1, 2024 \n\n[MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall](/news-releases/news-release-details/mimedx-showcases-leading-allograft-portfolio-and-its-latest)\n\n[](/node/18036/pdf)\n\nAugust 27, 2024 \n\n[MIMEDX to Participate in Upcoming Investor Conferences](/news-releases/news-release-details/mimedx-participate-upcoming-investor-conferences-5)\n\n[](/node/18011/pdf)\n\nJuly 31, 2024 \n\n[MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix](/news-releases/news-release-details/mimedx-announces-launch-heliogentm-fibrillar-collagen-matrix)\n\n[](/node/17981/pdf)\n\nJuly 31, 2024 \n\n[MIMEDX Announces Second Quarter 2024 Operating and Financial Results](/news-releases/news-release-details/mimedx-announces-second-quarter-2024-operating-and-financial)\n\n[](/node/17971/pdf)\n\nJuly 22, 2024 \n\n[MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports](/news-releases/news-release-details/mimedx-announces-publication-focused-surgical-applications-using)\n\n[](/node/17961/pdf)\n\nDisplaying 1 - 10 of 23 \n\n[ Print Page ]()\n\n**Print Page**\n\n[ RSS Feeds ](/rss-feeds)\n\n**RSS Feeds**\n\n[ E-mail Alerts ](/email-alerts)\n\n**E-mail Alerts**\n\n[ IR Contact ](/ir-contacts)\n\n**IR Contact**\n"
        }
      ]
    }
  ]
}